| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing > The American Demand for Office Furniture and Trends |
|
Main Subject - The American Demand for Office Furniture and Trends
The American office furniture industry performed very well throughout the 1990s as the domestic economy has shifted from being m According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product anufacturing driven to one where services play an increasingly important role. However, the new millennium has been less fortun ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ate for office furniture manufacturers. Between 2000 and 2003, office furniture shipments in the United States fell by more than lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. one-third. This was the largest decrease in shipments for over 20 years. The market has since recovered a bit reaching a value here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe of $10,070 million in 2005, but this is still more than $ 3,000 million below the 2000 peak level. Office employment growth cli d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro mbed only an estimate 1.8 percent this year. Next year may see another modest increase of 1.0 percent. In the years after 2007, ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc we anticipate office employment to advance at rates in the 1.7 to 2.0 percent range. Due to the relatively weak employment mar easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ket in officer intensive industries, office furniture sales will only hover around the 5 percent growth mark in the next few yea nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically rs. In current dollar terms, growth will be 1.5 to 2.0 percent higher than this. Wood office furniture accounted for $2,723 mil and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ lion of the total market for office furniture, or 27.0 percent in 2005. During the past ten years it fluctuated between 21.9 per ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi cent in1998 and 27.0 percent in 2005. Given the relatively more expensive nature, wooden office furniture is more likely to gain ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a market share when corporate earnings are strong rather than during periods of fiscal constraint. As of 2005 “Systems” represe dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod nted the largest market segment at over $2,600 million, or 28.8 percent of the total. Over the period 1995 to 2005 this segment cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin declined by 11.7 percent, compared to an average growth of 6.7 percent for the total office furniture industry. The fastest gro tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen wing segment was storage furniture which increased 50.2 percent over the last 10 years. Tables (up 31.2 percent), seating (up 12 t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel .7 percent), and desks (up 11.8 percent) also outpaced the overall office furniture industry. In sharp contrast, the filing cab ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust inet segment grew by only 3.2 percent between 1995 and 2005 as technology continues to transform office environments, reducing t y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products he relative demand for paper storage. California is by far the largest furniture market in the USA. As of 2005, this state acco . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de unted for more than $1,200 million of the total market, followed by Texas ($755 million), New York ($635 million), and Florida ( elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip $592 million). These four states collectively account for $3,182 million -- or more than 30% -- of the entire US market in 2005. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Business Background Check - It Pays to Know Someone Else's Business
|